
Antidote
Antidote is AI billing compliance software that checks and corrects law firm time entries against client billing guidelines.
Antidote vs Case Status
At a Glance
| Detail | Antidote | Case Status |
|---|---|---|
| Category | Practice Mgmt | Practice Mgmt |
| Total raised | $5M | $29.7M |
| Rounds tracked | 1 | 4 |
| Latest round | Seed, $5M · Jan 2026 | Series B, $19.7M · Oct 2024 |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | Lakestar | Grayhawk Capital, Topmark Partners, Panoramic Ventures, Meeting Street Capital |
| Built for | Large firms | Not disclosed |
| Headquarters | United Kingdom | United States |
Funding, Side by Side
Antidote rounds
- Jan 2026Seed$5M
Case Status rounds
- Oct 2024Series B$19.7M
- Dec 2022Series B$5M
- Jan 2022Series A$3.5M
- Mar 2020Seed$1.5M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Antidote or Case Status?
- Case Status has raised $29.7M in disclosed funding, compared with $5M for Antidote.
- Do Antidote and Case Status share investors?
- No. None of the investors we track have backed both companies.
- What is Antidote best for?
- Antidote is AI billing compliance software that checks and corrects law firm time entries against client billing guidelines.
- What is Case Status best for?
- Client communication app for law firms.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.
